“…However, this mechanism is not satisfactory when the size is greater than the well-known intrinsic healing capacity of bone tissues. Large bone defects caused by injury, disease, tumour ablation, or congenital malformations possess a tremendous challenge for orthopaedic or maxillofacial surgeons because the injury impairs blood supply and results in ischaemia, osteonecrosis, bone loss, or ultimately non-union (Dimitriou, Jones, McGonagle, & Giannoudis, 2011;Jeon et al, 2016;Lu et al, 2016;Lu, Chang, Lin, Li, & Hu, 2013;van Rijt & Habibovic, 2017 (Khaled, Saleh, Hindocha, Griffin, & Khan, 2011;Kimelman Bleich et al, 2012). However, it seems that using gene therapy for bone regeneration (Fliefel, Kuhnisch, Ehrenfeld, & Otto, 2017) is in the adulthood phase compared with iPSCs, which is still in the childhood phase as concluded from our systematic review.…”